This Award recognizes the company that has demonstrated industry leadership across a number of key criteria in the past 12 month period.
The criteria used to judge this category will be as follows:
- The range of services provided in niche and core therapeutic areas
- Methods of performance improvement or introduction of new services
- Attention to and quality of relationships with clients
- Reaching of milestones and final / ongoing outcomes
- Building and maintaining existing and long term partnerships
Winner: QUINTILES
Judges specific comments on the winner included:
• The recruitment of 11000+ children to a Phase III malaria vaccine trial and 13000 for a Phase IV trial in west Africa deserves serious credit.
• Their start-up times, enrolment and study durations consistently out performed the CMR benchmark in 2011.
Well done QUINTILES!
********************************************
Highly Regarded' recommendation: PharmaNet / i3 for their enrolment of 7,700 subjects for a global vaccine study in infants an 3,344 subjects in a a global vaccine study in elderly populations.